Navigation Links
Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
Date:7/25/2008

‘perceive’ had you only had the opportunity to remain longer in the creative state?" Those who responded positively were those who expressed a greater willingness to try methods to put them in a creative state. The other two parameters that influenced the respondents’ willingness to use the methods to put them in a creative state were:

“If it were in my power, I would want to increase this ratio” (inspiration/perspiration ratio)

and

- “I have a special method or technique (internal or external) for inducing creativity in myself.”

“Thanks to this survey, “ states Project Mind director David Devor, “It could be said that a small step has been made towards dramatically improving the standard of creativity in scientific research worldwide.”

For further information: David S. Devor: devor@usa.net

Complete survey results can be accessed at the following sites:

Survey Introduction Letter: http://www.projectmind.org/introletter.html
Survey: http://www.projectmind.org/survey.html
Analysis of Survey: http://www.projectmind.org/analysis.html
Voluntary Comments: http://www.projectmind.org/comments.html

For details on Project Mind: www.projectmind.org

David S. Devor
972-2-624-0280
devor @ usa.net

###

Read the full story at http://www.prweb.com/releases/2008/07/prweb1141974.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. MultiVu Video Feed: Allergan, Inc. Partners With "Project Runway" Designer Kara Saun and Gen Art Fresh Faces In Fashion to Raise Awareness About Excessive Underarm Sweating
2. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
3. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
4. AMDLs Jade Pharmaceutical Subsidiary Announces New Product Strategy; Six New Products, Including One With Sales Projected at Upwards of $10 Million, Under Development
5. Project on Emerging Nanotechnologies and Consumers Union collaborate on ConsumersTalkNano
6. Elbit Medical Imaging Ltd. Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore, India
7. Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania
8. Nano-Science Center to coordinate EU-project
9. ADM, MGSC and ISGS Announce Carbon Sequestration Project
10. Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
11. Credit-card-sized platform for volatile compound analysis CAREER project goal
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
Breaking Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6
Breaking Biology News(10 mins):The Academy of Natural Sciences and Temple Press revive rare natural history work in new book 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 1Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 2Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 3Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 4Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 57361 1Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 57361 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 1CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 3